长春高新 (000661)

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

ASZ

Tags

300ESG Index300 Non-Cyclical IndexAI HealthcareAI AgentsMSCI Component StocksSpecial Purpose LoansMid Cap ValueCSI 200 IndexGeneric DrugsSpin-off ListingsInnovation 100 IndexInnovative DrugsMedical Aesthetics ConceptPharmaceutical ManufacturingState-Owned Enterprise ReformGuozheng Value IndexGuozheng Corporate Governance IndexGene ConceptFund Heavy PositionsCSI 300 IndexBiological VaccinesHigh-Performing StocksMargin Trading and Securities LendingChina Securities Finance and Central Huijin HoldingsAssisted ReproductionNon-Cyclical StocksShenzhen Main Board 50 IndexSZSE 100 IndexSZSE 300 IndexSZSE 50 IndexSZSE Value IndexSZSE Governance Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 40793.75
  • Circulating A-Shares(W): 39961.46
  • Earnings Per Share(RMB): 2.9000
  • Net Assets Per Share(RMB): 56.3989
  • Operating Revenue(W RMB): 980661.29
  • Total Profit(W RMB): 118045.43
  • Net Profit Attributable to Parent(W RMB): 116487.99
  • Net Profit Growth Rate(%): -58.23
  • Weighted Return on Equity(%): 5.0300
  • Operating Cash Flow Per Share(RMB): 1.7700
  • Undistributed Profit Per Share(RMB): 43.1530
  • Capital Reserve Per Share(RMB): 8.5301

2. Main Business

The main business covers:

  • Research, development, production and sales of biopharmaceuticals and Chinese patent medicines
  • Real estate development and other businesses

3. Company Basic Information

  • Company Name: Changchun High-Tech Industry (Group) Co., Ltd.
  • Listing Date: 1996-12-18
  • Industry: Pharmaceutical Manufacturing
  • Address: 27th Floor, Block B, Hairong Plaza, High-tech Zone, Changchun City, Jilin Province (Intersection of Zhenyu Street and East Weishan Road)
  • Website: ccht.jl.cn
  • Company Profile: The company was exclusively initiated and established by Changchun High-tech Industry General Company in June 1993. Initially, its net assets were converted into 104.7 million state shares, 6 million corporate shares, and 26.8 million employee shares. After a 2.5:1 share consolidation in October 1996 and the first online pricing issuance on December 3, 1996, the total shares at listing were 68.64 million. The 5.36 million internal employee shares, which occupied the quota, were listed for trading together with its 13.64 million public shares on December 18, 1996.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Changchun Chaoda Investment Group Co., Ltd. General Legal Person 7625.65 19.08
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 974.51 2.44
3 Central Huijin Asset Management Co., Ltd. Special Legal Person 642.72 1.61
4 Huatai-PineBridge CSI 300 ETF Fund 551.83 1.38
5 China Merchants SSE Bio-medicine Index LOF (Class A) Fund 430.37 1.08
6 Xingquan Herun Hybrid LOF (Class A) Fund 412.79 1.03
7 E Fund CSI 300 Healthcare ETF Fund 409.12 1.02
8 E Fund CSI 300 ETF Fund 400.86 1.00
9 Yinhua CSI Innovative Pharma Industry ETF Fund 315.45 0.79
10 E Fund Healthcare Industry Hybrid (Class A) Fund 166.61 0.42

5. Concept Sectors

  • Biological Vaccine
  • Gene Concept
  • Generic Drug
  • Medical Aesthetics Concept
  • Assisted Reproduction
  • Innovative Drug
  • AI Agent
  • AI Healthcare
  • Margin Trading
  • Blue Chip Stock
  • Fund Heavy Holdings
  • Central Huijin & China Securities Finance
  • MSCI Constituent
  • Spin-off Listing
  • Non-cyclical Stock
  • Special Loan
  • SZSE Value
  • Mid-cap Value
  • SZSE 100
  • SZSE 300
  • SZSE Governance
  • SZSE Composite Governance
  • SZSE Composite Value
  • CSI 300
  • CSI 200
  • CSI 300 Non-Cyclical
  • Innovation 100
  • CSI 300 ESG
  • SOE Reform
  • SZSE 50
  • SZSE Main Board 50

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information